Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Celecoxib Inhibits Cdx2 Expression and Prevents Gastric Cancer in <i>Helicobacter pylori</i>-Infected Mongolian Gerbils

View through CrossRef
<i>Background/Aim:</i> The aim of this study was to see whether administration of celecoxib, a selective COX-2 inhibitor, prior to the appearance of intestinal metaplasia could prevent the development of gastric cancer in <i>Helicobacter pylori</i>-infected Mongolian gerbils. <i>Methods:</i>Fifty-two Mongolian gerbilswere divided into 3 groups and given 5 biweekly doses of N-methyl-N-nitrosourea (MNU; 30 ppm). At week 12, group 2 (n = 20) and group 3 (n = 22) gerbils were then given an injection of <i>H. pylori</i>, while group 1 controls (n = 10) received<i> Brucella</i> broth alone. In addition, 7 weeks after <i>H. pylori </i>inoculation, at week 19, group 3 gerbils also received a 36-week administration course of celecoxib (1,500 ppm) in their diet. The incidence of gastric adenocarcinoma was determined at week 54 by histological analysis. COX-2 and Cdx2 protein expression and COX activity were evaluated for each group. The extent of intestinal metaplasia, Cdx2 and MUC2 expression, and the apoptotic index were evaluated semi-quantitatively by immunohistochemistry. <i>Results:</i> The incidence of gastric adenocarcinoma was: group 1, 0% (0/10); group 2, 65% (13/20), and group 3, 23% (5/22; p < 0.05). Continuous celecoxib administration significantly reduced COX activity and COX-2 protein expression, Cdx2 and MUC2 protein immunoreactivity, and the extent of Alcian blue periodic acid-Schiff-positive intestinal metaplasia in <i>H. pylori</i>-infected gerbils. Celecoxib also induced apoptosis in these gerbils. Significant inhibition of Cdx2 expression in group 3 gerbils was also shown by Western blot analysis. <i>Conclusions:</i> Prior to the first appearance of intestinal metaplasia, timely administration of celecoxib prevents gastric cancer occurrence by disrupting the progression of intestinal metaplasia into gastric carcinoma through its inhibition of Cdx2 expression in MNU-pretreated <i>H. pylori</i>-infected Mongolian gerbils.
Title: Celecoxib Inhibits Cdx2 Expression and Prevents Gastric Cancer in <i>Helicobacter pylori</i>-Infected Mongolian Gerbils
Description:
<i>Background/Aim:</i> The aim of this study was to see whether administration of celecoxib, a selective COX-2 inhibitor, prior to the appearance of intestinal metaplasia could prevent the development of gastric cancer in <i>Helicobacter pylori</i>-infected Mongolian gerbils.
<i>Methods:</i>Fifty-two Mongolian gerbilswere divided into 3 groups and given 5 biweekly doses of N-methyl-N-nitrosourea (MNU; 30 ppm).
At week 12, group 2 (n = 20) and group 3 (n = 22) gerbils were then given an injection of <i>H.
pylori</i>, while group 1 controls (n = 10) received<i> Brucella</i> broth alone.
In addition, 7 weeks after <i>H.
pylori </i>inoculation, at week 19, group 3 gerbils also received a 36-week administration course of celecoxib (1,500 ppm) in their diet.
The incidence of gastric adenocarcinoma was determined at week 54 by histological analysis.
COX-2 and Cdx2 protein expression and COX activity were evaluated for each group.
The extent of intestinal metaplasia, Cdx2 and MUC2 expression, and the apoptotic index were evaluated semi-quantitatively by immunohistochemistry.
<i>Results:</i> The incidence of gastric adenocarcinoma was: group 1, 0% (0/10); group 2, 65% (13/20), and group 3, 23% (5/22; p < 0.
05).
Continuous celecoxib administration significantly reduced COX activity and COX-2 protein expression, Cdx2 and MUC2 protein immunoreactivity, and the extent of Alcian blue periodic acid-Schiff-positive intestinal metaplasia in <i>H.
pylori</i>-infected gerbils.
Celecoxib also induced apoptosis in these gerbils.
Significant inhibition of Cdx2 expression in group 3 gerbils was also shown by Western blot analysis.
<i>Conclusions:</i> Prior to the first appearance of intestinal metaplasia, timely administration of celecoxib prevents gastric cancer occurrence by disrupting the progression of intestinal metaplasia into gastric carcinoma through its inhibition of Cdx2 expression in MNU-pretreated <i>H.
pylori</i>-infected Mongolian gerbils.

Related Results

Effects of EGFR Inhibitor on Helicobacter pylori Induced Gastric Epithelial Pathology in Vivo
Effects of EGFR Inhibitor on Helicobacter pylori Induced Gastric Epithelial Pathology in Vivo
Helicobacter pylori transactivates the Epidermal Growth Factor Receptor (EGFR) and predisposes to gastric cancer development in humans and animal models. To examine the importance ...
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
<p dir="ltr"><b>Background</b></p><p dir="ltr">Helicobacter pylori (H. pylori) infects nearly half of the world's population and causes gastritis, pep...
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
<p dir="ltr"><b>Background</b></p><p dir="ltr">Helicobacter pylori (H. pylori) infects nearly half of the world's population and causes gastritis, pep...
Abstract 14077: Human Placental CDX2 Cells Are Multipotent and Differentiate Robustly to Cardiomyocytes
Abstract 14077: Human Placental CDX2 Cells Are Multipotent and Differentiate Robustly to Cardiomyocytes
Regenerative biology hinges on exploration of evolutionarily preserved healing mechanisms to maintain and restore homeostasis. CDX2 is one such conserved factor that regulates trop...
Helicobacter pylori and gastric cancer
Helicobacter pylori and gastric cancer
Introduction: According to GLOBOCAN estimates for 2018, gastric cancer was the fifth most common cancer and the third most common cause of death from malignant diseases in the worl...
Surface Antigen Profiling of Helicobacter pylori‐Infected and ‐Uninfected Gastric Cancer Cells Using Antibody Microarray
Surface Antigen Profiling of Helicobacter pylori‐Infected and ‐Uninfected Gastric Cancer Cells Using Antibody Microarray
AbstractBackgroundComprehensive immunophenotyping cluster of differentiation (CD) antigens in gastric adenocarcinoma, specifically between Helicobacter pylori‐infected and ‐uninfec...

Back to Top